查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1941478

生物感测器市场规模、份额和趋势分析报告：按技术、应用、最终用途、地区和细分市场预测（2026-2033 年）

Biosensors Market Size, Share & Trends Analysis Report By Technology (Electrochemical, Thermal, Piezoelectric), By Application (Medical, Bioreactor, Agriculture), By End Use (PoC Testing, Food Industry), By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

生物感测器市场概览

2025年全球生物感测器市场规模估计为322.1亿美元，预计2033年将达到639.6亿美元。

预计从 2026 年到 2033 年，生物感测器市场将以 9.12% 的复合年增长率成长。生物感测器需求不断增长的原因包括：医疗应用多样化、糖尿病和高血压等慢性病和非传染性疾病的盛行率不断上升、对小型诊断设备的需求量很大以及技术的快速进步。

对健康监测和健身追踪日益增长的需求，以及对个人化数位健康日益浓厚的兴趣，是推动市场成长的主要动力。此外，基于奈米技术的生物感测器预计将在包括食品分析、成像和微生物活性监测在内的各个工业领域中广泛应用。对非侵入式和穿戴式生物感测器的日益青睐、医疗设备和特种药品的日益普及，以及各製造商之间不断加强的研发合作，都在推动全球市场的整合。

此外，生物感测器能够对心率、睡眠模式、血氧饱和度、步数等生理指标进行连续、即时监测，为消费者和医疗保健专业人员提供可操作的数据。例如，根据亚利桑那大学健康科学学院2025年6月发表的一篇论文，先进的感测器平台将利用深度学习模型，根据高频生物特征资料预测生理事件，例如分娩的开始和压力反应。这些设备将作为早期警报系统，在症状出现之前检测健康风险，从而将医疗保健管理从被动应对转变为主动预防，并减轻延迟诊断和急诊护理的负担。

同样，Cardiosense公司的CardioTag也是这趋势的典型代表。它是一款获得FDA批准的可穿戴式多模态心臟监测感测器，整合了心电图（ECG）、光电容积脉搏波描记法（PPG）和地震心动图（SCG）讯号。 CardioTag利用先进的人工智慧演算法分析这些高精度讯号，能够早期检测心臟衰竭，进行全面的心臟评估，并提供个人化的治疗指导。它可在临床和家庭环境中非侵入性测量心臟动态、血流动力学（射血时间等）和容量状态。

此外，人工智慧、机器学习和感测器小型化技术的进步显着提升了穿戴式装置的功能和精确度。人工智慧演算法的整合实现了即时数据处理、预测分析和个人化回馈。在病患管理方面，Medtronic的Edge人工智慧胰岛素输注系统融合了生物感测器资料流，为动态调整胰岛素剂量提供临床层级的即时决策支援。该系统展示了人工智慧穿戴装置无需外部连接即可实现响应迅速的个人化干预的能力，从而支持门诊精准医疗。此外，由于指尖感测器测量精度的提高以及24小时佩戴舒适度的提升，智慧戒指也越来越受欢迎。

此外，产业内日益增多的伙伴关係与伙伴关係也促进了市场成长。例如，法国公司与国际公司之间的合作有助于扩大生产规模并进入全球市场，例如利文斯顿公司于2025年6月与一家全球生物感测器和穿戴式装置领域的Start-Ups合作。这种扩张反映了健身爱好者和都市区消费者对相关产品的日益增长的需求，从而推动了个人化健身、健康和生活方式应用的发展。

「自新冠疫情以来，诊断行业发生了变化，可穿戴技术变得越来越重要，人工智慧的影响力也越来越大。我们相信，与LinkSens的合作将使我们能够显着扩大市场份额，同时保持行业领先地位。”

「FlexMedical致力于执行长，」FlexMedical首席执行官兼联合创始人凯文法伦表示。

“透过此次合作，我们将整合功能化技术，拓展我们的生物感测器产品线，从而提供从柔性PCB和印刷电极到全功能感测器平台的端到端解决方案。我们将共同简化从研发到量产的流程，加速创新诊断解决方案的交付。”

Minh Le，LinkSens 医疗保健副总裁

目录

第一章调查方法和范围

第二章执行摘要

第三章 生物感测器市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 生物感测器市场分析工具
    • 产业分析：波特五力模型
    • PESTEL 分析

第四章 生物感测器市场：按应用分類的估算与趋势分析

  • 全球生物感测器市场应用变化分析
  • 全球生物感测器市场规模及趋势分析（按应用领域划分，2021-2033 年）
  • 医疗保健
    • 胆固醇
    • 血糖
    • 血气分析仪
    • 妊娠测试
    • 药物发现
    • 感染疾病
  • 食物毒性
  • 反应器
  • 农业
  • 环境
  • 其他的

第五章 生物感测器市场：依技术、预测与趋势分析

  • 全球生物感测器市场技术趋势与波动分析
  • 全球生物感测器市场规模及趋势分析（按技术划分，2021-2033 年）
  • 热感的
  • 电化学
  • 压电
  • 光学

第六章：生物感测器市场：最终用途、预测与趋势分析

  • 全球生物感测器市场按最终用途分類的差异分析
  • 全球生物感测器市场规模及趋势分析（按最终用途划分，2021-2033 年）
  • 居家医疗诊断
  • PoC测试
  • 食品工业
  • 研究所
  • 安全与生物防御

第七章 生物感测器市场：区域、预测与趋势分析

  • 2025年及2033年区域市占率分析
  • 区域市场概览
  • 市场规模及预测趋势分析，2021-2033年
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 公司/竞争对手分类
  • 策略规划
  • 2025年商业市场分析
  • 公司简介/列表
    • Abbott Laboratories
    • Medtronic
    • Biosensors International Group
    • Pinnacle Technology, Inc.
    • Dupont.
    • Sensirion AG
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann-La Roche AG
    • Siemens Healthineers
    • Zimmer & Peacock AS
    • Metrohm AG
    • DexCom, Inc.
    • Universal Biosensors, Inc.
    • Johnson & Johnson Services, Inc.
    • Nix Biosensors
    • Cyrcadia Health
    • Lifescan
Product Code: 978-1-68038-321-8

Biosensors Market Summary

The global biosensors market size was estimated at USD 32.21 billion in 2025 and is projected to reach USD 63.96 billion by 2033, growing at a CAGR of 9.12% from 2026 to 2033. The demand for biosensors is increasing due to the diversity of medical applications, growing prevalence of chronic and non-communicable diseases such as diabetes and hypertension, high demand for compact diagnostic devices, and rapid technological advancements.

The increasing demand for health monitoring and fitness tracking, coupled with rising interest in personalized digital wellness, is a primary driver in the growth of the market. In addition, nanotechnology-based biosensors are expected to have wide application scope in various industries, such as food analysis, imaging, and microbial activity monitoring. The global market is consolidating due to the growing preference for non-invasive wearable biosensors, rising popularity of medical devices & specialty drugs, and increasing research collaborations between various manufacturers.

Moreover, biosensors enable continuous, real-time monitoring of physiological metrics such as heart rate, sleep patterns, blood oxygen saturation, and steps taken, providing actionable data for consumers and healthcare professionals. For instance, according to an article published by the University of Arizona Health Sciences in June 2025, advanced sensor platforms use deep learning models to predict physiological events, including labor onset and stress response, from high-frequency biometric data. These devices serve as an early warning system to detect health risks prior to symptom onset. This approach transforms health management from episodic to proactive intervention, reducing the burden of late diagnoses and emergency care.

Similarly, the Cardiosense CardioTag is a significant example of this trend. It is an FDA-cleared, multimodal wearable sensor for cardiac monitoring, combining ECG (electrocardiogram), PPG (photoplethysmogram), and SCG (seismocardiogram) signals. It leverages advanced AI algorithms to analyze these high-fidelity signals for early heart failure detection, comprehensive cardiac assessment, and personalized therapy guidance, enabling noninvasive measurement of cardiac mechanics, hemodynamics (such as left ventricular ejection time), and volume status in both clinical and home settings.

Furthermore, advances in artificial intelligence, machine learning, and sensor miniaturization have significantly enhanced the functionality and accuracy of wearable devices. Integration of AI algorithms enables real-time data processing, predictive analytics, and personalized feedback. In patient management, Medtronic's edge AI-enabled insulin delivery systems demonstrate clinical-grade, real-time decision-making by fusing biosensor streams for dynamic insulin dose adjustment. This system highlights the capability of AI-enabled wearables to deliver responsive, personalized interventions without requiring external connectivity, thereby supporting precision medicine in ambulatory settings. In addition, smart rings are gaining traction due to improved measurement accuracy from finger-based sensors and enhanced comfort for 24-hour wear.

Furthermore, increasing partnerships and collaborations withing the industry contribute to market growth. For instance, partnerships between French firms and global startups, such as Livingston's collaboration for biosensors and wearables in June 2025, enable scalable production and global market reach. This expansion supports personalized fitness, wellness, and lifestyle applications, reflecting increasing adoption among fitness enthusiasts and urban consumers.

"The diagnostics industry has changed post COVID, wearable technology has risen up the agenda, along with AI having an increasing impact, and we think the collaboration with Linxens will keep us ahead of the curve while significantly improving our market reach."

Kevin Fallon, FlexMedical's CEO and co-founder,

"This collaboration expands our biosensor portfolio by integrating functionalisation capabilities, enabling us to deliver end-to-end solutions - from flex-PCB or printed electrodes to fully functional sensor platforms. Together, we streamline the journey from R&D to mass production, accelerating the delivery of innovative diagnostic solutions."

Minh Le, vice-president of Linxens Healthcare

Global Biosensors Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global biosensors market report based on technology, application, end use, and region.

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Thermal
  • Electrochemical
  • Piezoelectric
  • Optical
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Medical
    • Cholesterol
    • Blood Glucose
    • Blood gas analyzer
    • Pregnancy testing
    • Drug discovery
    • Infectious disease
  • Food Toxicity
  • Bioreactor
  • Agriculture
  • Environment
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Home Healthcare Diagnostics
  • PoC Testing
  • Food Industry
  • Research Laboratories
  • Security and Bio-defense
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Technology Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Biosensors Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. Biosensors Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Social Landscape

Chapter 4. Biosensors Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Biosensors Market Application Movement Analysis
  • 4.3. Global Biosensors Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 4.4. Medical
    • 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.2. Cholesterol
      • 4.4.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.3. Blood Glucose
      • 4.4.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.4. Blood Gas Analyzer
      • 4.4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.5. Pregnancy Testing
      • 4.4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.6. Drug Discovery
      • 4.4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.7. Infectious Disease
      • 4.4.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5. Food Toxicity
    • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6. Bioreactor
    • 4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7. Agriculture
    • 4.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.8. Environment
    • 4.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.9. Others
    • 4.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Biosensors Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Biosensors Market Technology Movement Analysis
  • 5.3. Global Biosensors Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 5.4. Thermal
    • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.5. Electrochemical
    • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.6. Piezoelectric
    • 5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.7. Optical
    • 5.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Biosensors Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Biosensors Market End Use Movement Analysis
  • 6.3. Global Biosensors Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Home Healthcare Diagnostics
    • 6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5. PoC Testing
    • 6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. Food Industry
    • 6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7. Research Laboratories
    • 6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.8. Security and Bio-defense
    • 6.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Biosensors Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2025
  • 8.4. Company Profiles/Listing
    • 8.4.1. Abbott Laboratories
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Medtronic
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Biosensors International Group
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Pinnacle Technology, Inc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Dupont.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Sensirion AG
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Thermo Fisher Scientific, Inc.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. F. Hoffmann-La Roche AG
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Siemens Healthineers
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Zimmer & Peacock AS
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. Metrohm AG
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. DexCom, Inc.
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Universal Biosensors, Inc.
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Product benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. Johnson & Johnson Services, Inc.
      • 8.4.14.1. Company overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Product benchmarking
      • 8.4.14.4. Strategic initiatives
    • 8.4.15. Nix Biosensors
      • 8.4.15.1. Company overview
      • 8.4.15.2. Financial performance
      • 8.4.15.3. Product benchmarking
      • 8.4.15.4. Strategic initiatives
    • 8.4.16. Cyrcadia Health
      • 8.4.16.1. Company overview
      • 8.4.16.2. Financial performance
      • 8.4.16.3. Product benchmarking
      • 8.4.16.4. Strategic initiatives
    • 8.4.17. Lifescan
      • 8.4.17.1. Company overview
      • 8.4.17.2. Financial performance
      • 8.4.17.3. Product benchmarking
      • 8.4.17.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global biosensors market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 4 Global biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 5 Global biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 6 North America biosensors market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 8 North America biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 9 North America biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 10 U.S. biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 11 U.S. biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 12 U.S. biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Canada biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 14 Canada biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 15 Canada biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 17 Mexico biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 18 Mexico biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Europe biosensors market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 21 Europe biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 22 Europe biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 23 UK biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 24 UK biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 25 UK biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 26 Germany biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 27 Germany biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 28 Germany biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 29 France biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 30 France biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 31 France biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Italy biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 33 Italy biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 34 Italy biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Spain biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 36 Spain biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 37 Spain biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 38 Denmark biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 39 Denmark biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 40 Denmark biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Sweden biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 42 Sweden biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 43 Sweden biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 44 Norway biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 45 Norway biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 46 Norway biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific biosensors market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 51 China biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 52 China biosensors market, by modality, 2021 - 2033 (USD Million)
  • Table 53 China biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 54 China biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 55 Japan biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 56 Japan biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 57 Japan biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 58 India biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 59 India biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 60 India biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 61 South Korea biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 62 South Korea biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 63 South Korea biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 64 Australia biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 65 Australia biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 66 Australia biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 67 Thailand biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 68 Thailand biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 69 Thailand biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 70 Latin America biosensors market, by country, 2021 - 2033 (USD Million)
  • Table 71 Latin America biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 72 Latin America biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 73 Latin America biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 74 Brazil biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 75 Brazil biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 76 Brazil biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 77 Argentina biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 78 Argentina biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 79 Argentina biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 80 MEA biosensors market, by country, 2021 - 2033 (USD Million)
  • Table 81 MEA biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 82 MEA biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 83 MEA biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 84 South Africa biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 85 South Africa biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 86 South Africa biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 90 UAE biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 91 UAE biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 92 UAE biosensors market, by end use, 2021 - 2033 (USD Million)
  • Table 93 Kuwait biosensors market, by application, 2021 - 2033 (USD Million)
  • Table 94 Kuwait biosensors market, by technology, 2021 - 2033 (USD Million)
  • Table 95 Kuwait biosensors market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Market formulation & validation
  • Fig. 5 Biosensors market: Market outlook
  • Fig. 6 Biosensors market: Segment outlook
  • Fig. 7 Biosensors market: Competitive landscape outlook
  • Fig. 8 Parent market outlook
  • Fig. 9 Biosensors market driver impact
  • Fig. 10 Biosensors market restraint impact
  • Fig. 11 Biosensors market: Technology outlook and key takeaways
  • Fig. 12 Biosensors market: Technology movement analysis
  • Fig. 13 Thermal market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Electrochemical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Piezoelectric market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Optical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Biosensors market: Application outlook and key takeaways
  • Fig. 18 Biosensors market: Application movement analysis
  • Fig. 19 Medical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Cholesterol market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Blood glucose market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Blood gas analyzer market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Pregnancy testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Drug discovery market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Infectious disease market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Food toxicity market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Bioreactor market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Agriculture market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Environment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Biosensors market: End use outlook and key takeaways
  • Fig. 32 Biosensors market: End use movement analysis
  • Fig. 33 Home healthcare diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 PoC testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Food industry market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Research laboratories market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Security and bio-defense market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Global biosensors market: Regional outlook and key takeaways
  • Fig. 39 Global biosensors market: Regional movement analysis
  • Fig. 40 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 U.S. key country dynamics
  • Fig. 42 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Canada key country dynamics
  • Fig. 44 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Mexico key country dynamics
  • Fig. 46 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 UK key country dynamics
  • Fig. 49 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Germany key country dynamics
  • Fig. 51 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 France key country dynamics
  • Fig. 53 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Italy key country dynamics
  • Fig. 55 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Spain key country dynamics
  • Fig. 57 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Denmark key country dynamics
  • Fig. 59 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Sweden key country dynamics
  • Fig. 61 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Norway key country dynamics
  • Fig. 63 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Japan key country dynamics
  • Fig. 66 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 China key country dynamics
  • Fig. 68 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 India key country dynamics
  • Fig. 70 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Thailand key country dynamics
  • Fig. 72 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 South Korea key country dynamics
  • Fig. 74 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Australia key country dynamics
  • Fig. 76 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Brazil key country dynamics
  • Fig. 79 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Argentina key country dynamics
  • Fig. 81 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 South Africa key country dynamics
  • Fig. 84 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Saudi Arabia key country dynamics
  • Fig. 86 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 UAE key country dynamics
  • Fig. 88 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Kuwait key country dynamics
  • Fig. 90 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)